Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phas...
Leadership
Peter A. Thompson FACP, M.D.Founder
Co-Founder & Independent Chairman
Kevin Koch Ph.D.
President, CEO & Director
Badreddin Edris Ph.D.Founder
Co-Founder & Independent Director
Alan J. Russell Ph.D.Founder
Co-Founder, Chief Scientific Officer & Director
Michael P. Nofi
Chief Financial Officer
Behrad Derakhshan Ph.D.
Chief Operating Officer
Joanne M. Donovan M.D., Ph.D.
Chief Medical Officer
John R. Moore J.D.
General Counsel
Aylin Tugcu
Senior Vice President of Cardiovascular Clinical Development & Medical Affairs
